Trademark applications and grants for Calixa Therapeutics Inc. Calixa Therapeutics Inc has 3 trademark applications. The latest application filed is for "ZINGRAM"
Patent Application | Date |
---|---|
CEFTOLOZANE-TAZOBACTAM PHARMACEUTICAL COMPOSITIONS 20150150883 - 14/531352 Jiang; Chun ;   et al. | 2015-06-04 |
SOLID FORMS OF CEFTOLOZANE 20150094293 - 14/289251 Jurkauskas; Valdas ;   et al. | 2015-04-02 |
METHODS FOR TREATING INTRAPULMONARY INFECTIONS 20150080360 - 14/550125 Chandorkar; Gurudatt A. ;   et al. | 2015-03-19 |
Treating Infections with Ceftolozane/Tazobactam in Subjects Having Impaired Renal Function 20150072968 - 14/286392 Krishna; Gopal ;   et al. | 2015-03-12 |
Tazobactam Arginine Compositions 20150072957 - 14/541890 Lai; Jan-Ji ;   et al. | 2015-03-12 |
Mark Image Registration | Serial | Trademark Application Date |
---|---|
![]() "ZINGRAM" 85904040 |
ZINGRAM 2013-04-15 |
![]() "PACTS" 85515941 |
PACTS 2012-01-13 |
![]() "CALIXA THERAPEUTICS" 77740058 |
CALIXA THERAPEUTICS 2009-05-19 |
SEC | 0001419892 | CALIXA THERAPEUTICS INC of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.